Next Article in Journal
Pharmaceutical Expenditure Forecast Model to Support Health Policy Decision Making
Previous Article in Journal
Challenges in Generating Costs and Utilisation Rates Associated with Castration-Resistant Prostate Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JMAHP
Volume 2
Issue 1
10.3402/jmahp.v2.24988
jmahp-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Health Economic Value of an Innovation: Delimiting the Scope and Framework of Future Market Entry Agreements

by
Robert Launois
1,*,
Lucia Fiestas Navarrete
1,
Olivier Ethgen
2,
Jean-Gabriel Le Moine
1 and
René Gatsinga
1
1
French Network for Evaluation in Health Economics, 28 rue d’Assas, FR-75006 Paris, France
2
Research Unit for the Economic Evaluation of Medical Innovation, University of Liege, Liege, Belgium
*
Author to whom correspondence should be addressed.
J. Mark. Access Health Policy 2014, 2(1), 24988; https://doi.org/10.3402/jmahp.v2.24988
Submission received: 9 January 2014 / Revised: 15 May 2014 / Accepted: 16 May 2014 / Published: 23 June 2014

Abstract

Background and objectives: The objective of our paper is to offer a new, payer-friendly taxonomy of market entry agreements (MEAs) that aims to twin contracts with their methodological designs in an effort to clarify the distinction between contracts that are based on performance and those that are based on demonstrated effect. Methods: Our analysis proceeds in two stages: First, we delimit the scope and framework of pay for performance (P4P) and pay for demonstrated effect (P4E) agreements. Second, we distinguish the methodological designs supporting the implementation of each of these contracts. Results: We elucidate why P4P contracts prevent the payer from funding the true effectiveness of an innovation by expanding on their limitations. These include: 1) the normative nature of comparisons, 2) the impossibility of true effect imputability for each individual, and 3) the use of intermediary outcome measures. We then explore three main criticisms that payers must take into account when reasoning in terms of performance rather than in terms of the product effectiveness. Conclusion: The potential effect that performance-based reimbursements may have on dissociating the components of the cost-effectiveness ratio constitutes an obstacle to a true health economic reasoning.
Keywords: risk sharing; pay for performance contract; comparative effectiveness research; cost-effectiveness studies risk sharing; pay for performance contract; comparative effectiveness research; cost-effectiveness studies

Share and Cite

MDPI and ACS Style

Launois, R.; Navarrete, L.F.; Ethgen, O.; Le Moine, J.-G.; Gatsinga, R. Health Economic Value of an Innovation: Delimiting the Scope and Framework of Future Market Entry Agreements. J. Mark. Access Health Policy 2014, 2, 24988. https://doi.org/10.3402/jmahp.v2.24988

AMA Style

Launois R, Navarrete LF, Ethgen O, Le Moine J-G, Gatsinga R. Health Economic Value of an Innovation: Delimiting the Scope and Framework of Future Market Entry Agreements. Journal of Market Access & Health Policy. 2014; 2(1):24988. https://doi.org/10.3402/jmahp.v2.24988

Chicago/Turabian Style

Launois, Robert, Lucia Fiestas Navarrete, Olivier Ethgen, Jean-Gabriel Le Moine, and René Gatsinga. 2014. "Health Economic Value of an Innovation: Delimiting the Scope and Framework of Future Market Entry Agreements" Journal of Market Access & Health Policy 2, no. 1: 24988. https://doi.org/10.3402/jmahp.v2.24988

APA Style

Launois, R., Navarrete, L. F., Ethgen, O., Le Moine, J. -G., & Gatsinga, R. (2014). Health Economic Value of an Innovation: Delimiting the Scope and Framework of Future Market Entry Agreements. Journal of Market Access & Health Policy, 2(1), 24988. https://doi.org/10.3402/jmahp.v2.24988

Article Metrics

Back to TopTop